Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nidadd in Hyperlipidemia
NCT00244231Phase 3Completed
- Sponsor
- Genovate Biotechnology
- Start
- Oct 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of niacin in hyperlipidemia, sponsored by Genovate Biotechnology. Started Oct 2003; status: completed.
02
Drugs
niacin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00244231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244231.